Jaguar Health Inc. (JAGX)
Jaguar Health Statistics
Share Statistics
Jaguar Health has 674K shares outstanding. The number of shares has increased by -86.58% in one year.
| Shares Outstanding | 674K |
| Shares Change (YoY) | -86.58% |
| Shares Change (QoQ) | 39.02% |
| Owned by Institutions (%) | 0% |
| Shares Floating | 562.28K |
| Failed to Deliver (FTD) Shares | 1.5K |
| FTD / Avg. Volume | 3.93% |
Short Selling Information
The latest short interest is 51.06K, so 7.78% of the outstanding shares have been sold short.
| Short Interest | 51.06K |
| Short % of Shares Out | 7.78% |
| Short % of Float | 7.79% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.01 and the forward PE ratio is -0.27. Jaguar Health's PEG ratio is 0.
| PE Ratio | -0.01 |
| Forward PE | -0.27 |
| PS Ratio | 0.03 |
| Forward PS | 0.2 |
| PB Ratio | 0.04 |
| P/FCF Ratio | -0.01 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Jaguar Health.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.63, with a Debt / Equity ratio of 5.01.
| Current Ratio | 1.63 |
| Quick Ratio | 1.11 |
| Debt / Equity | 5.01 |
| Debt / EBITDA | -1 |
| Debt / FCF | -1.24 |
| Interest Coverage | -133.47 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $238.55K |
| Profits Per Employee | $-785.55K |
| Employee Count | 49 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 0.19 |
Taxes
| Income Tax | -759K |
| Effective Tax Rate | 1.93% |
Stock Price Statistics
The stock price has increased by -90.58% in the last 52 weeks. The beta is 1.11, so Jaguar Health's price volatility has been higher than the market average.
| Beta | 1.11 |
| 52-Week Price Change | -90.58% |
| 50-Day Moving Average | 10.67 |
| 200-Day Moving Average | 23.27 |
| Relative Strength Index (RSI) | 57.58 |
| Average Volume (20 Days) | 38.06K |
Income Statement
In the last 12 months, Jaguar Health had revenue of 11.69M and earned -38.49M in profits. Earnings per share was -3267.25.
| Revenue | 11.69M |
| Gross Profit | 9.73M |
| Operating Income | -30.83M |
| Net Income | -38.49M |
| EBITDA | -36.66M |
| EBIT | -39.02M |
| Earnings Per Share (EPS) | -3267.25 |
Balance Sheet
The company has 8M in cash and 36.53M in debt, giving a net cash position of -28.52M.
| Cash & Cash Equivalents | 8M |
| Total Debt | 36.53M |
| Net Cash | -28.52M |
| Retained Earnings | -346.48M |
| Total Assets | 53.42M |
| Working Capital | 12.49M |
Cash Flow
In the last 12 months, operating cash flow was -29.38M and capital expenditures 0, giving a free cash flow of -29.38M.
| Operating Cash Flow | -29.38M |
| Capital Expenditures | 0 |
| Free Cash Flow | -29.38M |
| FCF Per Share | -2494.11 |
Margins
Gross margin is 83.27%, with operating and profit margins of -263.76% and -329.3%.
| Gross Margin | 83.27% |
| Operating Margin | -263.76% |
| Pretax Margin | -335.79% |
| Profit Margin | -329.3% |
| EBITDA Margin | -313.65% |
| EBIT Margin | -263.76% |
| FCF Margin | -251.38% |
Dividends & Yields
JAGX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for JAGX.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Mar 24, 2025. It was a backward split with a ratio of 1:25.
| Last Split Date | Mar 24, 2025 |
| Split Type | backward |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | -10.97 |
| Piotroski F-Score | 5 |